| Followers | 73 |
| Posts | 3281 |
| Boards Moderated | 0 |
| Alias Born | 03/16/2014 |
Friday, December 11, 2020 3:41:06 AM
Notbrad / Flip,
Why would extending warrants be a result of a perspective b/o when a b/o will buy all shares and warrants in their entirety ?
I think there is a deal in the offing , actually I think its already done, there has to be its unthinkable that LP hasn't built a relationship with key cancer pharma players.
She has the TLD and probably more than enough data to know just how good the results are and Merck will not require an explanation of the value of positive data.
The share price on the day the deal is struck will have zero to do with the price an acquirer pays therefore warrant extensions or not everything is priced on a fully diluted basis .
Why would extending warrants be a result of a perspective b/o when a b/o will buy all shares and warrants in their entirety ?
I think there is a deal in the offing , actually I think its already done, there has to be its unthinkable that LP hasn't built a relationship with key cancer pharma players.
She has the TLD and probably more than enough data to know just how good the results are and Merck will not require an explanation of the value of positive data.
The share price on the day the deal is struck will have zero to do with the price an acquirer pays therefore warrant extensions or not everything is priced on a fully diluted basis .
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
